An unusual complication after hyaluronate-based bioresorbable membrane (Seprafilm) application.
Recent developments in adhesion prevention have led to the introduction of a sodium hyaluranate-based bioresorbable membrane into clinical practice. Its application has been regarded as safe and efficient. We present three cases of postoperative acute aseptic peritonitis without an obvious etiology, which might have been related to this bioresorbable membrane during recent surgery. Surgeons should be aware of this kind of a complication that might be attributed to this product.
Remzi
Feza H
FH
Department of Colorectal Surgery, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.
Oncel
Mustafa
M
Church
James M
JM
Senagore
Anthony J
AJ
Delaney
Conor P
CP
Fazio
Victor W
VW
D000208:Acute Disease; D000328:Adult; D001672:Biocompatible Materials / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006820:Hyaluronic Acid; D008567:Membranes, Artificial; D010538:Peritonitis / Q000209:etiology*
D001672:Biocompatible Materials; D008567:Membranes, Artificial; C118198:Seprafilm; D006820:Hyaluronic Acid